OBJECTIVES: Many cardiac procedures using cardiopulmonary bypass (CPB) still require intraoperative transfusion. Retrograde autologous priming (RAP) has been introduced to decrease haemodilution and the blood transfusion rate. This study is designed to determine the influence or RAP on intraoperative haematocrit, transfusion and its clinical consequences.
INTRODUCTION
Over the past decades, the management of the cardiopulmonary bypass (CPB) system has been focusing on countering the high incidence of blood transfusion, related to the cardiac surgical procedure itself, and the problem of acute haemodilution, induced by the addition of the priming volume. To decrease the adverse clinical effects of homologous blood transfusion, several blood conservation techniques have been introduced in the perioperative setting, such as preoperative autologous blood donation, normovolemic haemodilution and cell salvage [1, 2] . Moreover, since it has been shown that a low haematocrit level during CPB has a detrimental effect on end-organ function as well as on cognitive outcome [3] [4] [5] [6] [7] , the technique of retrograde autologous priming (RAP) of the CPB circuit has regained interest, in order to decrease haemodilution. Previous studies have demonstrated the efficacy of RAP in the reduction of blood use after cardiac surgery, based on various small sample-sized and selected patient cohorts [8] [9] [10] [11] . However, Murphy et al. [12] failed to show its advantage on transfusion requirements in a larger population of 545 patients, undergoing a variety of cardiac surgical procedures, despite the higher haematocrit on CPB promoted by the RAP technique. In most series, the issue of RAP application has been addressed as a determinant on itself, regardless of the volume amount removed from the CPB circuit. The purpose of our study was to investigate the impact of RAP on the intraoperative haematocrit level and the consequent need for blood transfusion in a large, unselected population presenting for cardiac surgery, with specific emphasis on the effect of the RAP volume.
MATERIALS AND METHODS
All consecutive adult patients undergoing cardiac surgery at the University Hospital Ghent between April 2010 and December 2011 were eligible for the study. The exclusion criteria were off-pump coronary artery bypass surgery, need for deep hypothermic circulatory arrest, emergency and salvage procedures, heart transplantation and ventricular assist device implantation. All demographic, procedure-and CPB-related data were gathered from the local surgical and perfusion database. The Ethical Committee of the University Hospital of Ghent approved the study, without the need for informed patient consent (reference B670201214764). The data were analysed retrospectively.
Anaesthesia management
The anaesthetic technique at induction was standardized, including diazepam 0.1 mg kg and rocuronium 1 mg kg −1 . The lungs were ventilated mechanically with oxygen-enriched air (fractional inspired oxygen 0.5) adjusted to keep the end-tidal carbon dioxide around 30-35 mmHg. Anaesthesia was maintained with boluses of fentanyl up to a total dose of 20-30 µg kg −1 , together with the administration of sevoflurane, of which end-tidal concentrations were kept between 1 and 3%. Standard American Society of Anesthesiology-recommended monitoring was used throughout the procedure, combined with invasive arterial and central venous pressure measurements. After intubation, a multiplane transoesophageal echocardiographic probe was placed in the mid-oesophageal position to monitor intraoperative cardiac function. A bolus of 20 mg kg −1 of tranexamic acid was administered after induction followed by a continuous dose of 2 mg kg −1 h −1 and an extra bolus of 1 mg kg −1 just before the onset of CPB, unless the presence of clinical contraindications.
Cardiopulmonary bypass set-up
The disposable system consisted of a closed collapsible venous reservoir (CVR 1200, Sorin Group, Mirandola, Italy), an arterial filter (Sentry or D733 Micro 40 P, Sorin Group) and a membrane oxygenator (Avant or Eos, Sorin Group). A roller pump was used as an arterial pump in all cases. The complete system, with the exception of the cannulas, was phosporylcholine-coated (Phisio coating, Sorin Group). An autotransfusion device (Electa, Sorin Group) was mounted standby to collect intraoperative blood loss. The priming volume, for both the RAP and control group, consisted of a mixture of 800-1300 ml gelatin solution (Geloplasma, Fresenius Kabi, Schelle, Belgium), mannitol (0.5 mg kg ; Baxter, Lessines, Belgium) and 2500 IU of porcine heparin (Leo Pharma, Lier, Belgium) to achieve a total priming volume of 1000-1300 ml, depending on the system used.
Before cannulation, 3 mg kg −1 of porcine heparin (Leo Pharma) were administered. During CPB, activated clotting time (HR-ACT, Medtronic, Brussels, Belgium) was kept over 480 s.
During CPB run, a haematocrit level of 25% was the main target. If the calculated post-dilutional CPB haematocrit was >25%, autologous blood was withdrawn after induction. Failure to maintain this haematocrit level during the procedure, involved prompt addition of homologous packed red blood cells (PRBCs).
Whenever possible, pleuro-pericardial aspirations were collected separately and retransfused to the patient after autotransfusion device processing.
Mild-to-moderate hypothermia was maintained depending on the surgical procedure. Crystalloid cardioplegia (St. Thomas II), 600-1000 ml, was administered in all patients. A minimum blood flow of 2.4 l min −1 m −2 was targeted, while maintaining mixed venous saturation above 70%. Mean arterial blood pressure was maintained above 50 mmHg or higher depending on the clinical status of the patient. At the end of CPB, the residual blood volume of the extracorporeal circuit was slowly infused to the patient. Heparin reversal was achieved based on the Bull heparin sensitivity curve. The coagulation status of the patient was monitored before and after CPB by means of a Sonoclot device (Romed, Zoersel, Belgium).
Retrograde autologous priming technique
To perform RAP, a haemodilution bag (Beldico, Marche-enFamenne, Belgium) was connected to the arterial filter purge. Mild elevation of the patient's legs (30°) was done and, if necessary, a bolus of 50-200 μg of phenylephrine (West-Ward Pharmaceutical, Eatontown, NJ, USA) was administered in order to keep the systolic arterial blood pressure above 90 mmHg. When the sign was given to initiate CPB, priming solution in the arterial line was slowly replaced with blood from the patient through gravity drainage. Once the arterial filter was retrogradely filled with autologous blood, the arterial line was clamped. Clamps were removed from the venous line, and blood was slowly drained into the venous reservoir. Subsequently, the arterial pump was initiated, displacing the priming volume into the haemodilution bag. Once a sufficient amount of priming was discarded or patients became haemodynamically unstable, RAP was stopped, clamps were removed from the arterial line and CPB was instituted.
The decision to apply RAP was taken in agreement with the anaesthesiologist and the surgeon, based on preoperative status and procedure-related issues.
Statistical analysis
The distribution of data was tested for normality by the Kolmogorov-Smirnov test. Homogeneity of variance was done by the Levene test. Continuous data are expressed as mean ± standard deviation (SD), and categorical data as frequencies and percentage. The study population of 753 patients was divided into two groups based on the application of the RAP technique: a RAP group (n = 498) and a control group (n = 255). Betweengroup comparisons were made by the unpaired t-test and the chi-square test for continuous and categorical variables, respectively. Investigation of the independent determinants of nadir and end-haematocrit level during and at the end of CPB was performed by multivariate linear regression analysis via a stepwise backward model selection. Variables were eliminated when the P-value >0.1 in the univariate analysis. Risk factor analysis of intraoperative transfusion need was done by multivariate logistic regression through the same model selection method (stepwise backward likelihood ratio method).
Further evaluation of the optimal RAP volume in relation to transfusion requirement was explored with the classification tree method for the complete study population and for a selected population with a small body surface area (BSA) <1.7 m 2 , who potentially are at risk for increased perioperative transfusion. The obtained cut-off values of RAP volume were then assessed with receiver operating characteristic (ROC) curve analysis.
The impact of the RAP method on clinical outcome was based on end-points such as mortality, renal function impairment (defined as >50% increase of postoperative day-one creatinine level compared with the preoperative creatinine) and hospital length of stay, through respectively, chi-square and unpaired t-test analyses.
Statistical analysis was done with the SPSS 20.0 software (SPSS, Inc., Chicago, IL, USA). A P-value <0.05 was considered statistically significant.
RESULTS
Demographic patient data are presented in Table 1 . Although the gender difference was not significant, patients in the RAP group were, in general, smaller with a lower body weight, BSA and preoperative haematocrit. There was a significant difference in the type of surgical procedure with more multiple-valve surgery in the RAP group (P = 0.032). Nevertheless, procedural times were significantly shorter in the RAP group, most likely due to a higher number of isolated coronary artery bypass graft [243 (48.8%) patients in the group RAP vs 111 (43.5%) patients in the control group (P = 0.17)], although this difference was not significant.
The volumetric data are depicted in Table 2 . On average, a volume of 498 ± 221 ml was removed with RAP. The nadir haematocrit during CPB was significantly higher in the RAP group (26.78 SD 3.99 vs 25.79 SD 3.64; P = 0.001). However, the haematocrit on arrival at intensive care unit was comparable in the two groups (29.36% SD 3.61 in the RAP group vs 29.19% SD 2.96 in the control group, P = 0.52). Blood transfusion requirements were higher in the control group (0.58 SD 1.11 units/patient in the RAP group vs 0.89 SD 1.42 units/patient in the control group, P = 0.001). The difference in intraoperative crystalloid and/or colloid infusion by the anaesthesiologist was small but significant: 574.4 SD 332.5 ml for the RAP group vs 633.5 SD 314.2 ml in the control group (P = 0.041).
Multivariate analysis revealed that the nadir haematocrit was independently affected by severally female gender, BSA, preoperative haematocrit level, volume of anaesthesia fluid administration, CPB duration, circuit priming volume and RAP volume (Table 3) .
Regarding the perioperative blood transfusion requirements, logistic regression showed that CPB time, age, female gender, BSA, preoperative haematocrit, intraoperative crystalloid infusion and RAP volume were protective against the need for transfusion (Table 4 ). In addition, the amount of transfused PRBC units was negatively influenced by RAP volume (regression coefficient: −0.001; 95% confidence interval [CI]: −0.002-0.000; P = 0.001).
Based on the classification tree method, a RAP volume of 475 ml allowed a significant decrease of the transfusion rate from 28.5 to 23.7% (P = 0.003) for the whole study population. Accordingly, ROC curve analysis showed a weak but significant impact of RAP volume on intraoperative transfusion (area under the ROC curve 0.55; 95% CI 0.50-0.60; P = 0.039). Furthermore, for patients with a BSA of <1.7 m 2 , these findings even improved for a RAP volume of 375 ml by reducing the transfusion rate from 51.5 to 38.6% (P = 0.034). Here, the ROC area increased to 0.63 (95% CI 0.54-0.73; P = 0.008).
Concerning the clinical outcome, application of RAP did not induce major adverse events as illustrated by a comparable length of hospital stay (11.8 SD 9.8 vs 11.2 SD 9.5 days; P = 0.97), transient renal dysfunction (4.7 vs 6.0%; P = 0.46) and in-hospital 
DISCUSSION
The technique of intentional haemodilution was introduced into cardiac surgery some 50 years ago, thereby reducing the intraoperative exposure to allogenic blood transfusions and their potential harmful consequences [13] . On the other hand, the addition of non-haematic fluids to the patient's blood volume frequently results in a severe drop in haematocrit, jeopardizing the tissue oxygen delivery [14] . Furthermore, concerning this haemodilution effect, several large observational studies have found a direct association between the nadir haematocrit during CPB and increased perioperative morbidity and mortality [3] [4] [5] [6] [7] . It has been shown that low preoperative haematocrit, small body size and female gender predispose patients to severe haemodilution, necessitating intraoperative blood transfusion [15, 16] . The latter, however, carries an increased risk of postoperative complications such as sternal wound infections, renal and pulmonary dysfunction, prolonged intensive care and hospital stay and increased operative mortality [17, 18] .
In reply to these issues, various blood conservation strategies have been developed to reduce transfusion requirements, based on the use of pharmacological agents, autotransfusion devices, surface-coated CPB circuits, the reinfusion of washed mediastinal shed blood, the minimization of extracorporeal circuits, haemoconcentration and RAP [1, 2] . The latter two are techniques attempting to reduce haemodilution during CPB.
With the technique of haemoconcentration, one can extract the excess of fluid during CPB throughout the entire procedure. However, the correction of haemodilution by means of a haemoconcentrator is more slow and is unable to avoid a drop of haematocrit right at the start of CPB. Moreover, it creates an additional shunt in the extracorporeal system, requiring an increase in arterial pump flow. Nevertheless, the debate whether this technique reduces transfusion requirements is still ongoing. On the other hand, the RAP technique allows displacement of the crystalloid or colloid priming volume from the extracorporeal circuit by the patient's own blood just before the start of CPB and thus, this method can be executed only once.
The RAP method has regained interest, however, when Rosengart et al. [8] showed consistently higher haematocrit levels on CPB. Subsequently, their patients needed less intraoperative (3 vs 23%) as well as total hospital stay transfusion (27 vs 53%).
In accordance with other reports [8-11, 19, 20] , our results confirm the benefit of RAP on both nadir haematocrit and intraoperative transfusion rate, independently of known risk factors such as female gender, BSA and preoperative haematocrit and irrespective of the complexity of CPB-conducted cardiac procedures. In this analyses, focusing specifically on the RAP volume instead of the RAP technique itself, we showed that a minimal RAP volume of 475 ml is needed to obtain a significant decrease in the incidence of transfusion from 28.5 to 23.7%, representing an effective reduction in transfusion rate of 17%. The total RAP volume has to be calculated in function of the patient and its haemodynamic status at initiation of the surgical procedure. Smaller patients are prone to have a smaller circulating blood volume and so, the same RAP volume will have a greater effect on haemodilution than in larger patients. In small patients, with a BSA of <1.7 m 2 , often at risk of intraoperative transfusion, a RAP volume of 375 ml was already sufficient for an even superior effect: a reduction in transfusion rate of 25%. Hence, it is conceivable that RAP needs a critical volume for optimal effectiveness in many patients, while removal of larger volumes might be unnecessary or perhaps deleterious as in taller patients with normal preoperative haematocrit values [21] .
The efficacy of RAP has mainly been addressed by prospective randomized trials, on small cohorts of selected patients [8, 10, 19, 20, 22] . Our study was done in a large patient population undergoing a wide variety of surgical procedures, consistent with contemporary clinical practice. In a comparable study population, Murphy et al. [12] found no significant effect of RAP on the transfusion rate at the time of operation (23.3 vs 30.5%) nor at the end of the hospital stay (43.5 vs 51%), despite the higher haematocrit levels during CPB in the RAP group (26 vs 22%). However, there are some notable differences in comparison with our study conduct. First, in view of a final transfusion rate of 40-50%, the sample size might have been underpowered for a clear advantage of RAP. In addition, the lower transfusion trigger indicated by Murphy et al. includes that the degree of haemodilution needed to reach that trigger may exceed the volume Model statistics: stepwise backward logistic regression (likelihood ratio)-Naegelkerke R 2 = 0.71-probability of F to remove: P > 0.1. CI: confidence interval; CPB: cardiopulmonary bypass; Hct: haematocrit; RAP: retrograde autologous priming.
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K. Vandewiele et al. / Interactive CardioVascular and Thoracic Surgeryreduction achieved by the RAP technique and might underscore the lack of benefit by the RAP method on transfusion rate. Secondly, the amount of intraoperative crystalloid infusion was huge and even significantly higher in the RAP group (3000 vs 2700 ml without RAP), which certainly has affected the transfusion rate and weakened the effect of RAP. In our study, the additional volumes were small, commonly <1000 ml. Even more, the amount of fluid given by the anaesthesiologist to maintain haemodynamic stability independently influenced the nadir and end-haematocrit, as found by others [23] . Therefore, one might emphasize the importance of a close collaboration between all main participants involved in the surgical procedure and the CPB conduct, to optimize the perioperative clinical outcome by decreasing the intraoperative haemodilution and use of blood products. The haemodynamic management to facilitate the RAP application is of utmost importance, in order to remove the appropriate volume from the CPB circuit. Moreover, our data confirm [24] that this step can be accomplished without deleterious clinical consequences. Finally, the RAP technique can easily be included in a multimodality blood conservation algorithm to further decrease allogenic blood requirements, as stated by Helm et al. [25] .
Limitations of the study
Although our study might contribute to the knowledge of RAP application during cardiac surgery, it surely entails some limitations. In spite of including one of the largest patient cohorts on this item, its retrospective design might have induced some selection bias eventually in favour of RAP. RAP was more frequently applied in smaller patients with lower preoperative haematocrit values, but nevertheless, allogenic blood transfusion was significantly decreased in this patient group. Furthermore, the whole medical staff commonly pursues a stringent practice of reducing haemodilution and intraoperative blood transfusion, regardless of the intended RAP volume. However, we feel confident with the final conclusions from our data, indicating RAP volume as an independent predictor of decreased haemodilution and blood transfusion, as these reflect correctly our daily practice.
Conclusion
Our study shows that use of RAP decreases haemodilution and transfusion rate, during contemporary cardiac surgery using CPB. Particularly in the patients at risk of intraoperative transfusion, this technique offers additional benefit in a blood conservation strategy in a multidisciplinary team approach. What's more, the optimal RAP volume, rather than the technique itself, results to be critical to achieve the targeted haematocrit. This volume has to be tailored on the individual patient characteristics, independent of the procedure type. The optimal RAP volume, to achieve the targeted haematocrit, results to be critical and has to be based on an approach tailored on the individual patient characteristics and independent of the procedure type. However, our data need further confirmation in a prospective randomized trial, in order to define the cut-off limits of the optimal RAP volume for each cardiac surgery candidate. Vandewiele et al. presented an interesting paper on retrograde autologous priming (RAP), comprising a satisfactory number of patients [1] . RAP has been employed since the 1960s. The effects and applicability of RAP on haematocrit levels and transfusion requirements are well documented, but still it is not a routine method of cardiopulmonary bypass (CPB) priming due to controversies. This report objectively answers the questions concerning the efficacy of this procedure.
In this valuable report, we think that there are a few topics to be discussed. First, there is no data on whether the same surgeon or different surgeons operated on the patient. This issue is important since it directly affects perioperative blood loss and transfusion strategies.
The second topic addresses the effects of RAP on neurological complications. It is well-known that one of the major effects of maintaining adequate haematocrit levels during CPB is providing better neurological and neurocognitive functions following an operation [2] . However, the authors did not provide information on neurologic complications, such as stroke and delirium.
Finally, in the study, the authors stated that they used phosporylcholine-coated CPB circuits, which has been documented to have protective effects on blood loss and hematocrit levels [3, 4] . It is reported that haematocrit levels did not statistically differ between the groups on admission to intensive care unit, but the possible effects of phosporylcholine coated circuits on outcomes should also be mentioned.
In conclusion, we also believe that RAP is a very effective and accurate method for maintaining adequate haematocrit levels and lowering transfusion requirements. We, the readers thank the authors for sharing their knowledge and experiences.
Conflict of interest: none declared.
